Congress Celebrates 10 Years With Endorsements From Leading Professional Societies And Organizations

Main Category: Colorectal Cancer
Also Included In: GastroIntestinal / Gastroenterology;  Cancer / Oncology
Article Date: 20 Jun 2008 - 1:00 PDT

email to a friend   printer friendly   view / write opinions   rate article

As it celebrates its 10th year, the ESMO International Symposium: 10th World Congress on Gastrointestinal Cancer® has received endorsements from 6 leading professional societies and organizations, solidifying the reputation of the Congress as the premier platform for specialists in cancer research, leading oncologists and practicing clinicians to review the state-of-the-art in gastrointestinal cancer and share the latest information on its multidisciplinary management. The European Neuroendocrine Tumor Society (ENETS), European Oncology Nursing Society (EONS), European Organisation for Research and Treatment of Cancer (EORTC): Gastrointestinal Tumor Group, European School of Oncology (ESO), European Society of Surgical Oncology (ESSO), and Europacolon have indicated their support for the high quality of the scientific agenda and its educational value to oncology professionals. The European Society for Medical Oncology (ESMO) began its association with the Congress in 2005, and in 2008 brought the Congress under its educational wing as a partnership meeting.

In recognition of its 10 year history, Congress co-chair Eric Van Cutsem observed "We have much to celebrate from the past years. The number of deaths from colorectal cancer has been dropping as treatment has improved, allowing for more effective options for people with this diagnosis. However, there is still much work to be done. We are proud of our tradition of excellence in educating the medical community and look forward to continuing the journey."

The ESMO International Symposium: 10th World Congress on Gastrointestinal Cancer®, developed and managed by Imedex, begins next week in Barcelona, Spain, running from 25-28 June 2008. More than 3,300 healthcare providers from nearly 100 countries are expected to attend. The internationally recognized faculty will include 68 experts, chaired by Mario Dicato, MD of the Luxembourg Medical Center in Luxembourg and Eric Van Cutsem, MD, PhD of the University Hospital Gasthuisberg in Leuven, Belgium.

Designed to promote a multidisciplinary approach to treatment, the scientific agenda offers targeted sessions for oncology surgeons and nurses as well as a comprehensive range of topics for researchers, gastroenterologists, and medical and radiation oncologists. Presentation of cutting edge research has become one of the highlights of the Congress, as more than 400 abstracts have been accepted for publication in a special supplement of Annals of Oncology.

About Imedex

Imedex, LLC is an industry leader in providing accredited, independent continuing medical education (CME) worldwide. Imedex develops high quality, scientific programs that translate the latest research into clinically relevant information, improving patient care through education. The programs have a proven sustained impact on disease management, exceptional organization, and outstanding educational value. With 13,000 live meeting attendees and 120,000 e-learning experiences annually, Imedex educates the global healthcare community. Live, enduring, and e-learning programs focus on impacting the clinical management of patients around the world in the therapy areas of oncology, hematology, gastroenterology, infectious disease, urology, and psychiatry. Attendees consistently rate Imedex programs as excellent in terms of scientific quality, execution, and educational value.

Imedex

About the European Society for Medical Oncology (ESMO)

The European Society for Medical Oncology (ESMO) is the leading European non-profit, professional organization for medical oncology with a focus on promoting multidisciplinary cancer treatment around the world. ESMO unites medical oncologists, oncology specialists, healthcare professionals, caregivers, patients and policy makers in a global alliance committed to eradicating cancer and ensuring equal access to high quality treatment for all patients. Thanks to its state-of-the-art education and training programs, ESMO plays an instrumental role in providing the oncology community with the most up-to-date scientific research and information available. Through its flagship journal, Annals of Oncology, ESMO publishes articles on all aspects of clinical oncology. ESMO is dedicated to educating and supporting oncologists, optimizing patient care, disseminating cancer-specific information to the public, and advocating patient rights. As an authoritative voice in the fight against cancer, ESMO provides both the platform and the consultative expertise to influence national and international organizations as well as European authorities, in order to establish common standards for a multidisciplinary approach to cancer treatment.

European Society for Medical Oncology